Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.

van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA.

Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9. doi: 10.1016/j.drugalcdep.2011.12.007. Epub 2011 Dec 30.

PMID:
22209385
2.

Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.

Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, Kelley BJ, Schoener EP.

J Clin Psychiatry. 2000 Apr;61(4):244-51.

PMID:
10830144
3.

Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor?

Kousha M, Shahrivar Z, Alaghband-Rad J.

J Atten Disord. 2012 May;16(4):325-32. doi: 10.1177/1087054710387265. Epub 2011 Nov 29.

PMID:
22127397
4.
5.

Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.

Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M.

CNS Drugs. 2011 Feb;25(2):157-69. doi: 10.2165/11539440-000000000-00000.

PMID:
21254791
6.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
7.

Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates.

Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, Schwitzgebel P, Pinhard K, Dovi-Akue N, Wender P, Thome J.

Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):365-71. Epub 2004 Nov 12.

PMID:
15538605
8.

Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.

van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W; IASP Research Group.

Drug Alcohol Depend. 2014 Jan 1;134:158-66. doi: 10.1016/j.drugalcdep.2013.09.026. Epub 2013 Oct 5.

9.

Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.

Upadhyaya HP.

J Clin Psychiatry. 2007;68 Suppl 11:23-30. Review.

PMID:
18307378
10.

The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.

Fatseas M, Debrabant R, Auriacombe M.

Curr Opin Psychiatry. 2012 May;25(3):219-25. doi: 10.1097/YCO.0b013e3283523d7c. Review.

PMID:
22449768
11.

Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice.

Clure C, Brady KT, Saladin ME, Johnson D, Waid R, Rittenbury M.

Am J Drug Alcohol Abuse. 1999 Aug;25(3):441-8.

PMID:
10473007
12.

The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.

Schubiner H, Tzelepis A, Isaacson JH, Warbasse LH 3rd, Zacharek M, Musial J.

J Clin Psychiatry. 1995 Apr;56(4):146-50. Review.

PMID:
7713853
13.

[Attention-deficit/hyperactivity disorder and substance abuse].

Davids E, Gastpar M.

Psychiatr Prax. 2003 May;30(4):182-6. Review. German.

PMID:
12768521
14.
15.

Impact of substance use disorder on ADHD and its treatment.

Wilens TE, Upadhyaya HP.

J Clin Psychiatry. 2007 Aug;68(8):e20. Review.

PMID:
17876905
16.

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S; IASP research group, van den Brink W, Schoevers RA.

Addiction. 2014 Feb;109(2):262-72. doi: 10.1111/add.12370. Epub 2013 Nov 20.

17.

Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis.

Levin FR, Upadhyaya HP.

J Clin Psychiatry. 2007 Jul;68(7):e18. Review.

PMID:
17685729
18.

Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD).

Ohlmeier MD, Peters K, Te Wildt BT, Zedler M, Ziegenbein M, Wiese B, Emrich HM, Schneider U.

Alcohol Alcohol. 2008 May-Jun;43(3):300-4. doi: 10.1093/alcalc/agn014. Epub 2008 Mar 7.

19.

Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.

Goldstein BI, Bukstein OG.

J Clin Psychiatry. 2010 Mar;71(3):348-58. doi: 10.4088/JCP.09r05222gry. Epub 2009 Dec 1. Review.

PMID:
19961811
20.

[Substance use disorders and ADHD: an overview of recent Dutch research].

van Emmerik-van Oortmerssen K, Crunelle CL, Carpentier PJ.

Tijdschr Psychiatr. 2013;55(11):861-6. Review. Dutch.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk